Compare Abercrombie & Fitch Co. (ANF) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abercrombie & Fitch Co. vs Novavax Inc — how do they compare? Abercrombie & Fitch Co. trades at $115.48 (market cap $5.24B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Abercrombie & Fitch Co. is far larger — about 4× Novavax Inc's market cap, and Abercrombie & Fitch Co. is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| ANF | NVAX | |
|---|---|---|
Market Cap | $5.24B | $1.31B |
Sector | Consumer Cyclical | Health |
52-Week High | $129.85 | $11.19 |
52-Week Low | $65.61 | $6.22 |
Enterprise Value | $5.91B | $889.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abercrombie & Fitch Co.
Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumer through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.
Read more on ANF →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
